Centiloid scoring and tau PET quantification are the two new features in the company’s syngo.PET software application.

While lecanemab is approved for use in USA, Japan, China, South Korea and Israel, the European Medicines Agency (EMA) refused ...

We recently compiled a list of the 10 Best QQQ Stocks to Buy According to Analysts. In this article, we are going to take a ...

Zelik Bocknek is a retired business owner and lives in Toronto, Canada. Zelik is living with early Alzheimer’s disease and is ...

We recently compiled a list of the 10 Worst Performing NASDAQ Stocks in 2024. In this article, we are going to take a look at ...

Detailed price information for Annovis Bio Inc (ANVS-N) from The Globe and Mail including charting and trades.

European regulators have for the fourth time issued a negative opinion on PTC's Translarna. Elsewhere, Amylyx read out data ...

Prothena Corporation plc's stock has dropped 67% since my last “Buy” rating, primarily due to delays and a lack of meaningful ...

Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

Shared latest insights on brain image analysis used for prescription of Alzheimer's disease treatments such as 'Leqembi' and ...

Australia’s regulatory agency rejected Biogen and Eisai’s Alzheimer’s drug Leqembi, noting that the drug's efficacy doesn't ...

Australia's Therapeutic Goods Administration (TGA) has said it won't approve Eisai and Biogen's Alzheimer's disease therapy ...